BIOGEN INC.
Display and export data
General & Ratios
Financial Statements
/
In the 'original' view, the statements are displayed just as they are being reported by the company.
In the 'standardised' view, the statements are displayed in a standardised format (line items are identical for all companies).
Add data
Click on one of the orange fields in the profile to add new information
Edit or review data
Legend (for Financial Statements)
Passed value check (?)
Failed value check (?)
Click on a coloured field in the profile to review the data
Close sidebar
Loading: 100%
BIOGEN INC. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter Weston, United States of AmericaWeston, United States of Americano data available
Employees 7,400 (as per Q2 2017)no data available
Sector Biotechnology, HealthcareBiotechnology, Healthcareno data available
Ticker BIIBno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17240270300330360
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
 337.64n/a
Market Capitalisation
in million USD
 71,388n/a
Enterprise Value
in million USD
 74,997n/a
Common Shares Outstanding
as per Jul 21, 2017
 211,431,746n/a
Preferred Shares Outstanding
as per Jul 21, 2017
 8,000n/a
Average Basic Shares Outstanding
TTM
 215,750,000n/a
Average Diluted Shares Outstanding
TTM
 216,125,000n/a
Index Membership
n/a
Business Summary
Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological, rare and autoimmune diseases.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2017, million USD, full statements further below)
Profit & Loss
Revenues 11,717n/a
Gross Profit 10,171n/a
Operating Income 5,168n/a
EBITDA 6,340n/a
Net Profit 3,293n/a
Balance Sheet
Cash and Cash Equivalents 2,893n/a
Receivables 1,630n/a
Total Current Assets 7,109n/a
PP&E 2,828n/a
Total Assets 21,759n/a
Accounts Payable 330n/a
Current Debt 560n/a
Total Current Liabilities 3,380n/a
Long-Term Debt 5,954n/a
Total Liabilities 10,185n/a
Total Equity 11,574n/a
Cash Flow
Depreciation & Amortisation 1,172n/a
Change in Working Capital -656n/a
Operating Cash Flow 3,913n/a
Net Change in PP&E and Intangibles -1,732n/a
Investing Cash Flow -1,492n/a
Dividends Paid 0n/a
Financing Cash Flow -2,619n/a
Total Change in Cash -193n/a
Free Cash Flow 2,916n/a
Profitability Ratios
Gross Margin 86.8%n/a
Operating Margin 44.1%n/a
Net Profit Margin 28.1%n/a
Return on Equity 28.4%n/a
Return on Assets 15.1%n/a
Per Share Figures
Basic EPS 15.26n/a
Diluted EPS 15.23n/a
Sales per Share 54.31n/a
Book Value per Share 53.70n/a
FCF per Share 13.51n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio 22.12n/a
Price to Sales Ratio 6.22n/a
Price to Book Value 6.29n/a
Price to Free Cash Flow 24.99n/a
Valuation Metrics
EV/EBITDA 11.83n/a
EV/Sales 6.40n/a
Book to Market Value 0.16n/a
Other Ratios
Current Ratio 210.3%n/a
Liabilities to Equity Ratio 88.0%n/a
Debt to Assets Ratio 29.9%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
3,172
4,098
4,377
4,716
5,049
5,516
6,932
9,703
10,764
11,449
Sales & Services Revenue
3,063
3,968
4,248
4,547
4,833
5,304
6,668
9,399
10,528
11,132
Financing Revenue
0
0
0
0
0
0
0
0
0
0
Other Revenue
109
130
130
169
216
212
264
305
236
316
Cost of revenue
-335
-402
-382
-400
-467
-545
-858
-1,171
-1,240
-1,479
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
2,836
3,696
3,995
4,316
4,582
4,971
6,075
8,532
9,523
9,970
Other Operating Income
0
0
0
0
0
0
0
0
0
0
Operating Expenses
-1,973
-2,466
-2,700
-2,747
-2,802
-3,132
-3,585
-4,616
-4,509
-4,317
Selling, General & Administrative
-776
-925
-911
-1,032
-1,056
-1,277
-1,712
-2,232
-2,113
-1,948
Selling & Marketing
0
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
0
Research & Development
-925
-1,072
-1,283
-1,249
-1,220
-1,335
-1,444
-1,893
-2,013
-1,973
Depreciation & Amortization
-257
-333
-290
-209
-209
-202
-343
-490
-383
-386
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
0
Other Operating Expense
-14
-136
-216
-258
-318
-318
-85
0
0
-10
Operating Income (Loss)
864
1,229
1,295
1,569
1,780
1,838
2,490
3,917
5,015
5,653
Non-Operating Income (Loss)
72
-58
37
-19
-13
-1
-35
-26
-124
-217
Interest Expense, net
0
0
0
0
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
72
-58
37
-19
-13
-1
-35
-26
-124
-217
Pretax Income (Loss), Adjusted
936
1,172
1,333
1,550
1,766
1,838
2,455
3,891
4,891
5,436
Abnormal Gains (Losses)
-84
-16
0
-320
-55
17
25
56
-124
-503
Acquired In-Process R&D
-84
-25
0
-245
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
9
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
-36
-27
1
39
-31
-15
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
47
25
17
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
-455
Restructuring Charges
0
0
0
-75
-19
-2
0
0
-93
-33
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
852
1,156
1,333
1,230
1,711
1,855
2,481
3,947
4,767
4,933
Income Tax (Expense) Benefit, net
-272
-366
-356
-331
-445
-471
-601
-990
-1,162
-1,237
Current Income Tax
0
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
-5
-17
-15
-13
0
Income (Loss) from Continuing Operations
580
790
977
899
1,267
1,380
1,862
2,942
3,593
3,696
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
580
790
977
899
1,267
1,380
1,862
2,942
3,593
3,696
Minority Interest
58
-7
-7
107
-32
0
0
-7
-46
7
Net Income
638
783
970
1,005
1,234
1,380
1,862
2,935
3,547
3,703
Preferred Dividends
0
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
638
783
970
1,005
1,234
1,380
1,862
2,935
3,547
3,703
Remarks
restated on Feb 9, 2010 n/a
calculated values,
restated on Feb 4, 2011 n/a
calculated values,
restated on Feb 3, 2012 n/a
calculated values,
restated on Feb 5, 2013 n/a
calculated values,
restated on Feb 6, 2014 n/a
calculated values,
restated on Feb 4, 2015 n/a
calculated values,
restated on Feb 3, 2016 n/a
calculated values,
restated on Feb 2, 2017 n/a
calculated values,
restated on Feb 2, 2017 n/a
calculated values,
restated on Feb 2, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
1,342
1,264
1,208
1,691
1,706
1,223
1,845
3,429
4,895
Cash & Cash Equivalents
n/a
622
582
760
515
571
603
1,205
1,308
2,327
Short Term Investments
n/a
720
682
448
1,176
1,135
620
641
2,121
2,569
Accounts & Notes Receivable
n/a
447
551
605
585
687
824
1,292
1,227
1,442
Accounts Receivable, Net
n/a
447
551
605
585
687
824
1,292
1,227
1,442
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
0
Inventories
n/a
264
294
289
327
447
659
804
893
1,002
Raw Materials
n/a
0
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
406
372
438
373
404
479
593
1,151
1,394
Prepaid Expenses
n/a
0
0
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
406
372
438
373
404
479
593
1,151
1,394
Total Current Assets
n/a
2,458
2,481
2,540
2,975
3,244
3,185
4,535
6,700
8,732
Property, Plant & Equipment, Net
n/a
1,595
1,637
1,642
1,571
1,742
1,751
1,766
2,188
2,502
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
891
1,194
743
1,417
2,037
626
1,471
2,760
2,829
Long Term Investments
n/a
0
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
3,535
3,240
3,167
3,086
3,107
6,302
6,543
7,857
8,813
Intangible Assets
n/a
2,161
1,871
1,773
1,608
1,632
4,475
4,029
4,085
3,808
Goodwill
n/a
1,139
1,139
1,146
1,146
1,201
1,233
1,760
2,664
3,669
Other Intangible Assets
n/a
0
0
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
235
230
248
332
274
594
755
1,108
1,336
Total Noncurrent Assets
n/a
6,021
6,071
5,552
6,074
6,886
8,678
9,780
12,805
14,145
Total Assets
n/a
8,479
8,552
8,092
9,050
10,130
11,863
14,315
19,505
22,877
Liabilities and owners' equity
Payables & Accruals
n/a
107 107417000
119 118534000
163 162529000
186 186448000
204 203999000
220 219913000
229 229200000
267 267400000
280 279800000
Accounts Payable
n/a
107 107417000
119 118534000
163 162529000
186 186448000
204 203999000
220 219913000
229 229200000
267 267400000
280 279800000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Debt
n/a
28 27667000
20 19762000
137 137153000
3 3292000
453 453379000
3 3494000
3 3100000
5 4800000
5 4700000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
788 788138000
577 576646000
750 750440000
723 723149000
1,000 1000011000
1,535 1534872000
1,986 1985800000
2,306 2305500000
3,135 3135400000
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
788 788138000
577 576646000
750 750440000
723 723149000
1,000 1000011000
1,535 1534872000
1,986 1985800000
2,306 2305500000
3,135 3135400000
Total Current Liabilities
n/a
923 923222000
715 714942000
1,050 1050122000
913 912889000
1,657 1657389000
1,758 1758279000
2,218 2218100000
2,578 2577700000
3,420 3419900000
Long Term Debt
n/a
1,085 1085431000
1,080 1080207000
1,066 1066379000
1,061 1060808000
687 687396000
592 592433000
580 580300000
6,522 6521500000
6,513 6512700000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
636 636386000
495 494823000
527 526549000
649 648920000
822 821538000
892 891785000
702 702300000
1,031 1030700000
816 815600000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
356 356017000
241 240618000
201 200950000
249 248644000
217 217272000
233 232554000
52 52200000
125 124900000
93 93100000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
280 280369000
254 254205000
326 325599000
400 400276000
604 604266000
659 659231000
650 650100000
906 905800000
723 722500000
Total Noncurrent Liabilities
n/a
1,722 1721817000
1,575 1575030000
1,593 1592928000
1,710 1709728000
1,509 1508934000
1,484 1484218000
1,283 1282600000
7,552 7552200000
7,328 7328300000
Total Liabilities
n/a
2,645 2645039000
2,290 2289972000
2,643 2643050000
2,623 2622617000
3,166 3166323000
3,242 3242497000
3,501 3500700000
10,130 10129900000
10,748 10748200000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
6,074 6074106000
5,782 5782064000
3,895 3895227000
4,185 4185176000
3,855 3854652000
4,024 4023779000
4,196 4196300000
0 100000
0 100000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-527 -527097000
-680 -679920000
-350 -349592000
-840 -839903000
-1,325 -1324618000
-1,725 -1724927000
-2,612 -2611700000
-2,612 -2611700000
-2,612 -2611700000
Retained Earnings
n/a
270 270180000
1,069 1068890000
1,872 1872481000
3,107 3106761000
4,487 4486794000
6,349 6349135000
9,284 9283900000
12,208 12208400000
15,072 15071600000
Other Equity
n/a
-11 -11106000
50 50496000
-22 -21610000
-27 -26535000
-55 -55305000
-28 -27745000
-60 -59500000
-224 -224000000
-320 -319900000
Equity Before Minority Interest
n/a
5,806 5806083000
6,222 6221530000
5,397 5396506000
6,425 6425499000
6,962 6961523000
8,620 8620242000
10,809 10809000000
9,373 9372800000
12,140 12140100000
Minority Interest
n/a
28 27869000
40 40352000
53 52937000
1 1488000
2 2272000
1 596000
5 5000000
2 2100000
-12 -11500000
Total Equity
n/a
5,834 5833952000
6,262 6261882000
5,449 5449443000
6,427 6426987000
6,964 6963795000
8,621 8620838000
10,814 10814000000
9,375 9374900000
12,129 12128600000
Total Liabilities & Equity
n/a
8,479 8478991000
8,552 8551854000
8,092 8092493000
9,050 9049604000
10,130 10130118000
11,863 11863335000
14,315 14314700000
19,505 19504800000
22,877 22876800000
Remarks restated on n/a restated on Feb 9, 2010 n/a restated on Feb 4, 2011 n/a restated on Feb 3, 2012 n/a restated on Feb 5, 2013 n/a restated on Feb 6, 2014 n/a restated on Feb 4, 2015 n/a restated on Feb 3, 2016 n/a restated on Feb 2, 2017 n/a restated on Jul 25, 2017 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
580
790
977
899
1,267
1,380
1,862
2,942
3,593
3,696
Net Income
0
0
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
380
462
428
356
359
366
532
688
600
683
Non-Cash Items
138
136
21
367
287
30
-136
-203
98
71
Stock-Based Compensation
123
146
161
168
113
119
136
155
161
155
Deferred Income Taxes
-82
-140
-137
-81
154
-117
-245
-308
-146
-175
Other Non-Cash Adjustments
97
129
-2
280
20
29
-28
-50
82
91
Change in Working Capital
-80
174
-351
4
-185
104
88
-484
-576
73
(Increase) Decrease in Accounts Receivable
-71
-58
-100
-99
-73
4
-127
-512
29
-241
(Increase) Decrease in Inventories
-83
-54
-43
-5
-59
-140
-244
-186
-174
-166
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
74
286
-208
107
-52
240
458
214
-430
480
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
0
0
Cash from Operating Activities
1,019
1,562
1,075
1,625
1,728
1,880
2,345
2,942
3,716
4,522
Change in Fixed Assets & Intangibles
-267
-276
-166
-173
-208
-255
-3,509
-316
-643
-728
Disposition of Fixed Assets & Intangibles
17
0
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
17
0
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
-284
-276
-166
-173
-208
-255
-3,509
-316
-643
-728
Purchase of Fixed Assets
-284
-276
-166
-173
-208
-255
-246
-288
-643
-616
Acquisition of Intangible Assets
0
0
0
0
0
0
-3,263
-28
0
-112
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
209
-223
-229
680
-1,420
-585
1,912
-864
-2,802
-534
Decrease in Long Term Investment
3,154
2,941
3,319
2,669
2,277
2,750
5,190
2,719
4,063
7,379
Increase in Long Term Investment
-2,945
-3,164
-3,548
-1,988
-3,697
-3,334
-3,278
-3,583
-6,865
-7,913
Net Cash From Acquisitions & Divestitures
-96
-25
0
-157
-5
-72
0
0
-199
0
Net Cash from Divestitures
0
0
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
-96
-25
0
-157
-5
-72
0
0
-199
0
Other Investing Activities
-132
158
0
-4
-17
-39
-8
-363
-910
-1,223
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
-287
-366
-395
345
-1,650
-950
-1,605
-1,543
-4,554
-2,485
Dividends Paid
0
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
1,494
-525
-11
-18
-11
-2
-452
-3
5,928
-3
Cash From (Repayment of) Short Term Debt, net
1,501
-525
-11
-18
-11
-2
-452
-3
5,928
-3
Cash From (Repayment of) Long Term Debt, net
-7
0
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
-7
0
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
-2,502
-560
-703
-1,894
-183
-917
-334
-832
-4,946
-956
Increase in Capital Stock
489
178
48
183
315
67
67
55
54
44
Decrease in Capital Stock
-2,991
-739
-751
-2,078
-498
-985
-400
-887
-5,000
-1,000
Other Financing Activities
274
-149
-10
127
-125
42
69
79
4
-29
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
-733
-1,235
-724
-1,785
-320
-877
-717
-756
986
-988
Net Cash Before Disc. Operations and FX
-1
-38
-44
185
-242
52
24
643
149
1,050
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
0
0
Net Cash Before FX
-1
-38
-44
185
-242
52
24
643
149
1,050
Effect of Foreign Exchange Rates
-1
1
4
-7
-3
4
8
-41
-46
-31
Net Changes in Cash
-2
-37
-40
178
-245
56
32
602
103
1,019
Remarks
restated on Feb 9, 2010 n/a
calculated values,
restated on Feb 4, 2011 n/a
calculated values,
restated on Feb 3, 2012 n/a
calculated values,
restated on Feb 5, 2013 n/a
calculated values,
restated on Feb 6, 2014 n/a
calculated values,
restated on Feb 4, 2015 n/a
calculated values,
restated on Feb 3, 2016 n/a
calculated values,
restated on Feb 2, 2017 n/a
calculated values,
restated on Feb 2, 2017 n/a
calculated values,
restated on Feb 2, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
About | Contact Forum | Legal
SimFin UG 2017 - Beta v. 1.42
Facebook | Twitter | Medium
Sumo